Mindbio Therapeutics CEO Issues Letter To Shareholders

Dear Shareholders,We are delighted to provide an update on progress at MindBio, as we head into the second half of 2024 and continue with dosing in multiple Phase 2B clinical trials and we advance the

BenzingaJul 8 08:40 ET

Express News | Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

ReutersJun 21 16:01 ET

Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) fell sharply during Friday's session after the company announced pricing of $6.0 million public offering.Kaival Brands priced its 3,921,50

BenzingaJun 21 14:04 ET

Sector Update: Health Care Stocks Steady Premarket Friday

Health care stocks were steady premarket Friday with the Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) inactive recently. Sarepta Therapeutics (SRPT) rallie

MT NewswiresJun 21 09:12 ET

Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike

USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer...

PR NewswireJun 20 17:26 ET

Mustang Bio to Raise $2.5 Million From Share Offering

Mustang Bio (MBIO) said late Thursday it expects to raise $2.5 million from a registered direct offering of 6.13 million shares at $0.41 each.

MT NewswiresJun 20 17:06 ET